Popular filter options for gerd trials
Gastroesophageal Reflux Disease Clinical Trials With No Placebo
View 21 gastroesophageal reflux disease medical studies that do not have a placebo group.
Positional Therapy with LEFT Device for Acid Reflux
This trial will enroll 120 GERD patients who will be randomly assigned to either the intervention group or the control group. The intervention group will be asked to use the LEFT device for four weeks while the control group will be given general lifestyle and dietary recommendations.
View More Gerd Trials
See another 2 medical studies focused on gerd.
Frequently Asked Questions
Introduction to gerd
What are the top hospitals conducting gerd research?
Gastroesophageal reflux disease (GERD) affects millions of people worldwide, causing discomfort and potentially leading to serious complications. In the quest for effective treatments, several top hospitals have emerged as leaders in conducting clinical trials dedicated to this condition. One such institution is Vanderbilt University Medical Center located in Nashville. With two ongoing GERD trials and a cumulative total of six trials carried out over the years, Vanderbilt has been actively involved in researching this disorder since recording its first trial back in 2005.
Additionally, Mayo Clinic Florida situated in Jacksonville has also made significant contributions to GERD research. Currently conducting one active trial and having completed two previous investigations, Mayo Clinic Florida recorded its inaugural trial targeting GERD symptoms just ten years ago in 2012.
Further north, the Medical College of Wisconsin based in Milwaukee stands out with its commitment to advancing knowledge about GERD through clinical trials. This esteemed institution boasts one ongoing trial focused on this condition while having conducted two additional studies since their pioneering endeavor commenced in 2011.
Meanwhile, Reza Shaker Hospital located within Milwaukee mirrors the dedication towards investigating new avenues for treating GERD with one currently active clinical trial alongside an accomplished history of one prior study dating back only seven years ago to 2014.
Lastly but not least Kansas City VA Hospital playing a crucial role by dedicating itself into thoroughly studying gerd's varied dimensions; it sets off with scheduling on-going investigation focusing solely into addressing Gerd related issues joining hands together along-with other major institutions contributing greatly creating milestones furthering our understanding regarding finding practical approaches that will benefit patients around globe starting from2022 onwards
These esteemed hospitals are at the forefront of groundbreaking research aimed at improving outcomes for those affected by GERD. Their tireless efforts pave the way for potential breakthroughs that may revolutionize treatment options and provide much-needed relief for individuals living with this chronic condition
Which are the best cities for gerd clinical trials?
In the realm of GERD clinical trials, several cities have emerged as prominent hubs for research and innovation. Nashville, Tennessee; Atlanta, Georgia; Miami, Florida; Jacksonville, Florida; and Milwaukee, Wisconsin all offer opportunities to participate in active studies investigating various treatments like BLI5100 High Dose, Dexlansoprazole, Breath Test Evaluation for SIBO, commercially available lansoprazole, and more. With each city hosting multiple ongoing trials focused on advancing our understanding and management of GERD symptoms and complications.
Which are the top treatments for gerd being explored in clinical trials?
The search for effective treatments for GERD (gastroesophageal reflux disease) is an ongoing endeavor in clinical trials. Currently, several promising options are under investigation:
- EsoGuard: with 7 active trials and a total of 32 all-time GERD trials since its inception
- Baclofen: being explored in 5 ongoing clinical studies specifically targeting GERD
- LINX Reflux Management System: a popular option with 4 active trials dedicated to finding new insights into its effectiveness.
What are the most recent clinical trials for gerd?
Promising advancements in the field of gastroesophageal reflux disease (GERD) have emerged through recent clinical trials. One notable study focused on the effectiveness of BLI5100 at higher doses, aiming to provide improved outcomes for GERD patients. Another trial investigated a new drug product specifically designed to address the symptoms and underlying causes of GERD. Dexlansoprazole, another innovative treatment option, showed encouraging results in Phase 2 testing. Additionally, speech language therapy demonstrated potential benefits in managing GERD-related complications during both Phase 1 and Phase 2 trials. With these groundbreaking studies paving the way forward, individuals suffering from GERD can anticipate promising developments that may offer relief and improve their quality of life.
What gerd clinical trials were recently completed?
Recently, several significant clinical trials in the field of gastroesophageal reflux disease (GERD) have been completed. In May 2022 and January 2022, Phathom Pharmaceuticals successfully concluded separate trials evaluating the effectiveness of Vonoprazan for GERD treatment. Additionally, a trial sponsored by Northwestern University investigated dexlansoprazole for GERD management and was completed in July 2017. These studies contribute to the expanding body of knowledge surrounding GERD therapies, offering potential benefits to individuals affected by this common digestive disorder.